[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-CSN-131026005--":3,"related-articles-undefined-undefined-3b0c143a-1ddd-4edc-8eae-c9192ac88aac-true":15},{"id":4,"type":5,"title":6,"pubDate":7,"logoUrl":8,"anpFeedCategory":9,"organisationTitle":10,"thirdParty":11,"body":12,"orgId":13,"description":14},"CSN-131026005","PRESSRELEASE"," GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration","2026-10-13T02:16:25.000+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Fimg\u002Fpr-newswire.png","Economie","PR Newswire",true,"\u003Cp> Linking North American and Asia-Pacific Capabilities to Support Joint Sales and Project Execution\u003C\u002Fp>\u003Cp> SEOUL, South Korea and RALEIGH, N.C., Oct. 13, 2026 \u002FPRNewswire\u002F -- GCCL, a South Korea-based leading global clinical trial central laboratory represented by CEO Kwan-goo Cho, announced today that it signed a Memorandum of Understanding (MOU) with LabConnect on October 12 to expand global clinical trial collaboration. LabConnect is a global central laboratory and clinical trial samples solutions partner.\u003C\u002Fp>\u003Cp> Built on a collaborative relationship spanning more than 20 years, this agreement aims to improve the operational efficiency of global clinical trial projects by linking the regional capabilities and expertise of both companies across North America and the Asia-Pacific (APAC) region.\u003C\u002Fp>\u003Cp> The signing ceremony, held at GCCL's headquarters, was attended by key executives from both organizations, including GCCL CEO Kwan-goo Cho and from LabConnect, Jeff Mayhew, Founder and Strategic Commercial Advisor, and Joshua Gentile, Senior Vice President, Head of Commercial Sales and Marketing. During the event, the two companies shared their core services and future visions, discussing key collaborative initiatives, including:\u003C\u002Fp>\u003Cp> - Identifying potential clients and supporting sales within each region\u003C\u002Fp>\u003Cp> - Integrating global clinical trials and central laboratory services\u003C\u002Fp>\u003Cp> - Cooperating on project management and client communications\u003C\u002Fp>\u003Cp> - Formulating joint marketing strategies and identifying new business opportunities\u003C\u002Fp>\u003Cp> Under this agreement, GCCL and LabConnect plan to establish a mutual collaboration framework leveraging their respective regional strengths and partner relationships. Furthermore, the companies intend to drive joint sales and marketing initiatives while setting up shared systems and processes for client responses and project management.\u003C\u002Fp>\u003Cp> \"Through this collaboration with GCCL, we expect to simplify and orchestrate complex studies conducted in South Korea and the Asia-Pacific region,\" said Jeff Mayhew, Founder and Strategic Commercial Advisor of LabConnect. \"Pairing GCCL's laboratory and logistics strength with our global alliance of clinical and specialty laboratories, along with proactive sample logistics oversight and intervention, provides sponsors a more coordinated path for multi-regional studies.\"\u003C\u002Fp>\u003Cp> Kwan-goo Cho, CEO of GCCL, stated, \"This MOU marks the starting point of connecting GCCL's execution capabilities in the APAC region with LabConnect's comprehensive global alliance of clinical and specialty laboratories. We are committed to building a practical collaborative framework spanning joint sales, project execution, and client management to accelerate our global clinical trial business.\"\u003C\u002Fp>\u003Cp> About LabConnect\u003C\u002Fp>\u003Cp> LabConnect® is a global central laboratory services and clinical trial sample solutions partner, connecting the full sample journey, from biomarker strategy and custom kitting through testing, storage, and submission-ready data. The company combines scientific and operational expertise, its global alliance of clinical and specialty laboratories, worldwide logistics oversight, and integrated data services to support routine and specialized testing across complex global studies. LabConnect helps pharmaceutical, biotechnology, and contract research organizations reduce operational risk, improve study predictability, and generate meaningful insights from each sample. Visit LabConnect.com.\u003C\u002Fp>\u003Cp> About GCCLGCCL, a subsidiary of the GC Group, is a leading clinical trial sample analysis provider offering an integrated \"one-stop lab solution\" with central, bioanalysis, and BSL-3 labs under one system. With tailored solutions, GCCL delivers precise and efficient analytical services across all phases of clinical trials, solidifying its position as a trusted partner in new drug development. Leveraging advanced platforms and LIMS, the company supports partners across Asia and beyond with customized and compliant solutions. In recognition of its leadership, GCCL recently received Frost & Sullivan's 2025 Best Practices Customer Value Leadership Award in the Asia-Pacific clinical sample analysis services industry.\u003C\u002Fp>\u003Cp> View original content to download multimedia:https:\u002F\u002Fwww.prnewswire.co.uk\u002Fnews-releases\u002Fgccl-and-labconnect-sign-mou-to-expand-global-clinical-trial-collaboration-302906198.html\u003C\u002Fp>","3b0c143a-1ddd-4edc-8eae-c9192ac88aac","Linking North American and Asia-Pacific Capabilities to Support Joint Sales and Project Execution SEOUL, South Korea and RALEIGH, N.C., Oct. 13, 2026 \u002FPRNewswir",[16,21,26,27,32,37,42,47,52,57],{"id":17,"title":18,"pubDate":19,"logoUrl":8,"thirdParty":11,"orgId":13,"description":20},"CSN-131026013"," GFI Builds Eloquens® AI Directly Into GFI KerioConnect®, Bringing an AI Email Assistant to More Than 30,000 Organizations That Run Their Own Mail","2026-10-13T06:16:25.000+02:00","Announced in Prague at ZEBR.AI Roadshow Praha 2026: GFI KerioConnect with embedded AI mail assistant delivers personalized, bespoke handling of user emails PRAG",{"id":22,"title":23,"pubDate":24,"logoUrl":8,"thirdParty":11,"orgId":13,"description":25},"CSN-131026008"," Bybit ondersteunt aandelenhandel en geeft daarmee in aanmerking komende gebruikers wereldwijd toegang tot meer dan 1.000 Amerikaanse aandelen en ","2026-10-13T03:27:24.000+02:00","DUBAI, VAE, 13 oktober 2026 \u002FPRNewswire\u002F -- Bybit, The New Financial Platform, dat wereldwijd het vertrouwen geniet van meer dan 80 miljoen gebruikers, heeft be",{"id":4,"title":6,"pubDate":7,"logoUrl":8,"thirdParty":11,"orgId":13,"description":14},{"id":28,"title":29,"pubDate":30,"logoUrl":8,"thirdParty":11,"orgId":13,"description":31},"CSN-131026001"," CHANGAN Enters a New Phase of European Growth at Mondial de l'Auto 2026","2026-10-13T00:34:25.000+02:00","CHANGAN NEVO debut, broader powertrain offerings and deeper local operations underline CHANGAN's long-term commitment to Europe PARIS, Oct. 12, 2026 \u002FPRNewswire",{"id":33,"title":34,"pubDate":35,"logoUrl":8,"thirdParty":11,"orgId":13,"description":36},"CSN-121026161"," SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease","2026-10-12T20:04:25.000+02:00","LUCERNE, Switzerland and NEW DELHI, Oct. 12, 2026 \u002FPRNewswire\u002F -- The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the ",{"id":38,"title":39,"pubDate":40,"logoUrl":8,"thirdParty":11,"orgId":13,"description":41},"CSN-121026154"," Cell Impact announces acceleration of previously communicated order from US customer","2026-10-12T19:09:25.000+02:00","KARLSKOGA, Sweden, Oct. 12, 2026 \u002FPRNewswire\u002F -- In June, Cell Impact announced that the company had received a follow-up order for the production of flow plate",{"id":43,"title":44,"pubDate":45,"logoUrl":8,"thirdParty":11,"orgId":13,"description":46},"CSN-121026149"," Fraikin announces exclusive agreement with Asterion Industrial Partners to support its next phase of growth","2026-10-12T18:40:26.000+02:00","PARIS, Oct. 12, 2026 \u002FPRNewswire\u002F -- The management of Fraikin, a leading pan-European provider of commercial vehicle leasing and fleet solutions platform, toda",{"id":48,"title":49,"pubDate":50,"logoUrl":8,"thirdParty":11,"orgId":13,"description":51},"CSN-121026140"," Lucid Sets Plan for First Retail and Service Locations in France","2026-10-12T17:46:25.000+02:00","- Lucid will open its first three retail and service locations in the first quarter of 2027. - Lucid plans to expand its French network to more than 16 partner ",{"id":53,"title":54,"pubDate":55,"logoUrl":8,"thirdParty":11,"orgId":13,"description":56},"CSN-121026131"," Malou Oheix from France Wins First Place in 2026 Herbie Hancock Institute International Jazz Vocals Competition at Fondation Louis Vuitton","2026-10-12T17:26:25.000+02:00","Hosted by Jeremy Irons, honoring Arturo Sandoval with tribute to Frank Gehry introduced by Special Guest Gustavo Dudamel PARIS, Oct. 12, 2026 \u002FPRNewswire\u002F -- Ma",{"id":58,"title":59,"pubDate":60,"logoUrl":8,"thirdParty":11,"orgId":13,"description":61},"CSN-121026124"," FORTHING Debuts TK Series at Paris Motor Show, Driving Global Expansion with Technology","2026-10-12T16:28:25.000+02:00","PARIS, Oct. 12, 2026 \u002FPRNewswire\u002F -- The Paris Motor Show 2026 opened on October 12. Under the theme \"FOR THINGS THAT MATTER,\" FORTHING showcased four models—TK"]